4.8 Article

Sensitive in vivo imaging of T cells using a membrane-bound Gaussia princeps luciferase

Journal

NATURE MEDICINE
Volume 15, Issue 3, Pages 338-344

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nm.1930

Keywords

-

Funding

  1. US National Institutes of Health [CA95152, CA059350, CA08748, CA086438, CA096945, CA094060, CA083084]
  2. Alliance for Cancer Gene Therapy
  3. Damon Runyon Clinical Investigator Award
  4. Canada Club of New York, Kate's Team
  5. Commonwealth Cancer Foundation for Research and the Experimental Therapeutics Center of MSKCC
  6. Geoffrey Beene Cancer Foundation
  7. Chronic Lymphocytic Leukemia Foundation
  8. Ludwig Center for Cancer Immunotherapy
  9. Bocina Cancer Research Fund

Ask authors/readers for more resources

We developed a new approach to bioluminescent T cell imaging using a membrane-anchored form of the Gaussia luciferase (GLuc) enzyme, termed extGLuc, which we could stably express in both mouse and human primary T cells. In vitro, extGLuc(+) cells emitted significantly higher bioluminescent signal when compared to cells expressing GLuc, Renilla luciferase (RLuc) or membrane-anchored RLuc (extRLuc). In vivo, mouse extGLuc(+) T cells showed higher bioluminescent signal when compared to GLuc(+) and RLuc(+) T cells. Application of this imaging approach to human T cells genetically modified to express tumor-specific chimeric antigen receptors (CARs) enabled us to show in vivo CAR-mediated T cell accumulation in tumor, T cell persistence over time and concomitant imaging of T cells and tumor cells modified to express firefly luciferase. This sensitive imaging technology has application to many in vivo cell-based studies in a wide array of mouse models.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available